Eskayef has entered a technology transfer arrangement with Novo Nordisk, which supplies roughly 40 percent of Bangladesh's insulin demand, marking a shift from reliance on imports.

Eskayef Pharmaceuticals, one of the country’s top pharmaceutical companies, has set up Bangladesh’s first manufacturing facility to produce insulin cartridges, a positive development for the millions of local diabetic patients.